Physician profile
Augustine E Agocha
NPI 1003863135
$3,031.35
in general payments reported to CMS, 2019-2025
16 companies · $795 in 2025
The $795 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $133 · 2021: $193 · 2022: $272 · 2023: $444 · 2024: $659 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,897.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $513.84 | 2019-2025 | Andexxa, Farxiga, Wainua |
| Abbott Laboratories | $415.05 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Novartis Pharmaceuticals Corporation | $410.11 | 2019-2022 | |
| Pfizer INC. | $319.59 | 2019-2025 | |
| Cvrx, INC. | $195.43 | 2022-2025 | Barostim Neo System |
| Nuwellis, INC. | $191.03 | 2019-2025 | Aquadex Smartflow Console |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.57 | 2019-2024 | Jardiance |
| Abiomed | $159.65 | 2025 | |
| Boston Scientific Corporation | $159.33 | 2025 | Resonate El Icd Vr, Latitude Communicator Power Supply, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $159.02 | 2024 | Cobalt Dr Mri Surescan |
| Atricure, INC. | $156.92 | 2023-2025 | Atriclip Laa Exclusion System |
| Scpharmaceuticals INC. | $99.69 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $38.09 | 2024-2025 | Eliquis, Camzyos |
| Actelion Pharmaceuticals US, INC. | $17.96 | 2019 | |
| Bard Peripheral Vascular, INC. | $14.07 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augustine Agocha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.